Literature DB >> 27702854

Incidence of silent cerebral infarctions after catheter ablation of atrial fibrillation utilizing the second-generation cryoballoon.

Tomofumi Nakamura1, Kaoru Okishige1, Toshiro Kanazawa2, Mitsumi Yamashita1, Naohiko Kawaguchi1, Nobutaka Kato1, Hideshi Aoyagi1, Yasuteru Yamauchi1, Tetsuo Sasano3, Kenzo Hirao3.   

Abstract

AIMS: Pulmonary vein (PV) isolation (PVI) utilizing a cryoballoon (CB) has become one of the standard therapeutic options for atrial fibrillation (AF). However, it connotes a potential risk of cerebral ischaemic events (CIEs). This study aimed to clarify the prevalence of CIEs after PVI using second-generation CBs assessed by magnetic resonance imaging (MRI) of the brain. METHODS AND
RESULTS: This prospective observational study consisted of 160 patients that underwent PVI with second-generation CBs for drug-refractory AF. Irrigated radiofrequency (RF) ablation for 'touch-up' procedures was utilized when conduction gaps between the left atrium (LA) and PVs were found after the CB application. Radiofrequency linear ablation was added in select patients. Cerebral MRI and neurological examinations were performed on the day following the ablation procedure. The MRI depicted micro-cerebral infarctions in 43 patients (26.9%, 1.49 lesions per case). All patients were free from symptomatic focal neurological deficits. Touch up ablation was required for the PVI establishment in 35 patients (21.9%). Linear ablation was performed in 59 patients (36.9%). Additional RF ablation within the LA was an independent risk of CIEs in the uni- and multivariate analyses. When the analyses were limited to patients who had undergone only CB ablation, CIEs were found in 12 of 66 patients (18.2%).
CONCLUSION: Pulmonary vein isolation utilizing second-generation CBs carries a negligible risk of symptomatic CIEs; however, it includes a comparable risk of asymptomatic CIEs as in the previous similar reports using the first-generation CB. Radiofrequency applications in addition to the CB within the LA were the only predictor of this adverse effect. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Cerebral infarction; Cryoballoon; Pulmonary vein isolation

Mesh:

Year:  2017        PMID: 27702854     DOI: 10.1093/europace/euw191

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  7 in total

1.  Comparative Study of Cryoballoon versus Radiofrequency for Pulmonary Vein Isolation when Combined with vein of Marshall Ethanol Infusion for Paroxysmal Atrial Fibrillation.

Authors:  Kaoru Okishige; Naohiko Kawaguchi; Shinsuke Iwai; Yasuteru Yamauchi; Takehiko Keida; Tetsuo Sasano; Kenzo Hirao; Miguel Valderrabano
Journal:  J Atr Fibrillation       Date:  2020-02-28

2.  Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation.

Authors:  Paulus Kirchhof; Karl Georg Haeusler; Benjamin Blank; Joseph De Bono; David Callans; Arif Elvan; Thomas Fetsch; Isabelle C Van Gelder; Philip Gentlesk; Massimo Grimaldi; Jim Hansen; Gerhard Hindricks; Hussein R Al-Khalidi; Tyler Massaro; Lluis Mont; Jens Cosedis Nielsen; Georg Nölker; Jonathan P Piccini; Tom De Potter; Daniel Scherr; Ulrich Schotten; Sakis Themistoclakis; Derick Todd; Johan Vijgen; Luigi Di Biase
Journal:  Eur Heart J       Date:  2018-08-21       Impact factor: 29.983

3.  Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation: A meta-analysis.

Authors:  Indranill Basu-Ray; Dibbendhu Khanra; Péter Kupó; Jared Bunch; Sue A Theus; Anindya Mukherjee; Sumit K Shah; András Komócsi; Adedayo Adeboye; John Jefferies
Journal:  J Arrhythm       Date:  2021-01-29

Review 4.  Prevention of Dementia in Patients with Atrial Fibrillation.

Authors:  Daehoon Kim; Pil Sung Yang; Boyoung Joung
Journal:  Korean Circ J       Date:  2021-04       Impact factor: 3.243

5.  Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism.

Authors:  Jie Zheng; Meng Wang; Qun-Feng Tang; Feng Xue; Ku-Lin Li; Shi-Peng Dang; Xiao-Yu Liu; Xiao-Xi Zhao; Chang-Ying Zhang; Zhi-Ming Yu; Bing Han; Ting-Bo Jiang; Yan Yao; Ru-Xing Wang
Journal:  Front Cardiovasc Med       Date:  2021-12-01

6.  Effect of air removal with extracorporeal balloon inflation on incidence of asymptomatic cerebral embolism during cryoballoon ablation of atrial fibrillation: A prospective randomized study.

Authors:  Masaaki Yokoyama; Michifumi Tokuda; Kenichi Tokutake; Hidenori Sato; Hirotsuna Oseto; Kenichi Yokoyama; Mika Kato; Ryohsuke Narui; Shin-Ichi Tanigawa; Seigo Yamashita; Michihiro Yoshimura; Teiichi Yamane
Journal:  Int J Cardiol Heart Vasc       Date:  2022-04-07

7.  Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5.

Authors:  Mariëlle Kloosterman; Winnie Chua; Larissa Fabritz; Hussein R Al-Khalidi; Ulrich Schotten; Jens C Nielsen; Jonathan P Piccini; Luigi Di Biase; Karl Georg Häusler; Derick Todd; Lluis Mont; Isabelle C Van Gelder; Paulus Kirchhof
Journal:  Europace       Date:  2020-07-01       Impact factor: 5.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.